Get the latest Science News and Discoveries

Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer

None

Related news:

Phase III MAVERICK trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer

Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer

Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC